November 7-8, 2022
Delivered as a Hybrid EventInn at Penn a Hilton Hotel, Philadelphia, PANovember 7-8, 2022
Delivered as a Hybrid Event,
Inn at Penn a Hilton Hotel, Philadelphia, PA
SHAPING THE MEDICAL AFFAIRS ORGANIZATION OF THE FUTURE TO DRIVE VALUE CREATION AND DELIVER PATIENT-CENTRIC OUTCOMES
CONVENING US AND GLOBAL HEADS OF MEDICAL AFFAIRS TO MAP A JOINT VISION TO DRIVE DIGITAL TRANSFORMATION, EVOLVE ENGAGEMENT MODELS AND HARNESS BIG DATA AND RWE TO INFORM CORPORATE STRATEGY
Redefining Your Learning Experience
EXPLORE THE NEXT EVOLUTION OF THE MEDICAL AFFAIRS FUNCTION AS PATIENT-CENTRIC HEALTHCARE EVOLVES
- Examine different "fit for purpose" organizational models for medical affairs and the rationale for what makes them effective
- Address the increasing role of medical affairs in driving product launch strategy
- Ensure corporate strategy goals encompass the medical affairs function
EMBRACE DIGITAL TRANSFORMATION, EVOLVE ENGAGEMENT MODELS AND ADOPT EMERGING TECHNOLOGIES FOR BETTER DECISION MAKING
- Empower digital strategy leaders to partner with digital companies that can lead you to the most innovative and dynamic engagement models that are highly responsive to the changing information needs (how they want to receive data) of external stakeholder needs
- Consider the pandemic's impact on accelerating digital engagement with HCPs and how medical affairs can foster these new engagement models to ensure continued value for HCPs
- Garner expertise to manage the influx of big data as well as meaningful analysis and interpretation of the data
SUPPORT CROSS FUNCTIONAL BUSINESS STRATEGY THROUGH EARLIER COLLABORATION EFFORTS
- Map out the next steps in deepening earlier collaboration efforts with R&D to ensure patient voice drives development throughout the drug development life cycle
- Establish a collaborative commercial and medical affairs interface – Determine the right scope and breadth of partnership with Commercial
- Review collaboration efforts with R&D and Commercial to manage compliance risk
INCORPORATE AN ENTERPRISE-WIDE PATIENT CENTRICITY FOCUS TO AMPLIFY THE PATIENT VOICE
- Define medical affair's role in determining and driving patient engagement strategy
- Discuss best practices for working directly with patients, patient organizations, family members and caretakers to better understand the patient journey
- Consider what role medical affairs can play in advancing health equity and clinical trial diversity
MOVE THE NEEDLE IN COMMUNICATING THE VALUE OF MEDICAL AFFAIRS BY LEVERAGING CRITICAL INSIGHTS AND RWE TO INFORM CORPORATE STRATEGY
- Review best practices for synthesizing the abundance of external insights into a streamlined approach to guide medical affairs activities globally and align with R&D Commercial
- Explore current trends in how medical affairs organizations are providing a more complete data package by leveraging RWE data generation and analysis
- Discuss progress in establishing a critical few KPIs that can measure the value of medical affairs
Who Should Attend
You will benefit from attending this event if you are a SVP, VP, Head, CMO, Executive Director, Senior Director, Director from the bio/pharmaceutical industry with responsibilities or involvement in the following areas:
Medical Affairs / Communications / Information
Medical / Scientific Information
Education / Operations / Operational Excellence
Clinical Development
Medical Engagement and Innovation
Digital Strategy / Transformation
HEOR / Evidence Generation
Real World Evidence
Data Analytics
Informatics
This congress will also benefit consultants and medical education providers who provide services to med device and pharmaceutical medical affairs teams.
Connect and Network with Key Decision-Makers at the Medical Affairs Congress
Whether you’re looking to generate quality leads, showcase thought leaders, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.
For more information about custom opportunities to reach a qualified audience, contact us here.